Allergy, Asthma, and Atopic Eczema in Finland
NCT06330974 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000000
Last updated 2024-03-26
Summary
The summary is available at --\> https://www.finnatopy.fi/summary
Conditions
- Asthma
- Asthma in Children
- Allergy
- Rhinitis, Allergic
- Atopic Dermatitis
- Allergen Immunotherapy
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Professor Lauri Lehtimäki
collaborator UNKNOWN -
Professor Mika Mäkelä
collaborator UNKNOWN -
Professor Sanna Toppila-Salmi
collaborator UNKNOWN -
Professor Ilkka Junttila
collaborator UNKNOWN -
Tampere University
lead OTHER
Principal Investigators
-
Péter Csonka · Tampere University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2032-12-31
- Completion
- 2034-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Impact of AIT on Allergic Rhinitis and Asthma
NCT04125888 ·Status: COMPLETED
-
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835 ·Status: UNKNOWN
-
House Dust Mite SLIT in Elderly Patients
NCT01605760 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Allergic Rhinitis on Educational Outcomes
NCT05881577 ·Status: UNKNOWN
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)
NCT01549340 ·Status: COMPLETED
-
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
NCT01433523 ·Status: COMPLETED ·Phase: PHASE3
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
NCT03375775 ·Status: COMPLETED ·Phase: NA
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy
NCT00540150 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT01506843 ·Status: COMPLETED ·Phase: NA
-
Inhibitory Receptors in Eosinophils of Atopic Subjects
NCT01489293 ·Status: COMPLETED
-
AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)
NCT02238353 ·Status: UNKNOWN ·Phase: PHASE4
-
Integrative Omics Approach to Allergic Rhinitis
NCT03324100 ·Status: ACTIVE_NOT_RECRUITING
-
Local IgE in Subjects With Allergic or Non-allergic Rhinitis
NCT02810535 ·Status: COMPLETED ·Phase: NA
-
Mite Asthma Pediatric Immunotherapy Trial
NCT03654976 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
NCT02214303 ·Status: UNKNOWN
-
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma
NCT05476484 ·Status: UNKNOWN
-
Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
NCT01052610 ·Status: UNKNOWN ·Phase: PHASE4
-
e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma
NCT06021912 ·Status: UNKNOWN